phosphotyrosine has been researched along with captopril in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brenelli, SL; Carvalho, CR; Carvalho, DS; Saad, MJ; Villaça, V | 1 |
Carvalho, CR; Moisés, RS; Saad, MJ; Shiota, D | 1 |
2 other study(ies) available for phosphotyrosine and captopril
Article | Year |
---|---|
Angiotensin-converting enzyme inhibitor increases insulin-induced pp185 phosphorylation in liver and muscle of obese rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Liver; Male; Muscle, Skeletal; Obesity; Phosphoproteins; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Receptor, Insulin | 1998 |
Evidence for a direct effect of captopril on early steps of insulin action in BC3H-1 myocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Captopril; Cell Line; Deoxyglucose; Glucose; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C3H; Muscles; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Insulin | 2003 |